Genome-wide association studies for the identification of biomarkers in metabolic diseases

Expert Opinion on Medical Diagnostics

Volumn 4, Issue 1, 2010, Pages 39-51

  Pattin, Kristine A ^a   Moore, Jason H ^a,b,c,d,e  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Department of Computer Science ^*  (United States)

^c Department of Computer Science ^*  (United States)

^d TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

Genome wide association studies; Obesity; Single nucleotide polymorphisms; Type II diabetes

Indexed keywords

BIOLOGICAL MARKER;

DISEASE PREDISPOSITION; GENETIC VARIABILITY; GENOME; GENOTYPE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; REVIEW;

EID: 77953391029     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530050903322245     Document Type: Review

References (110)

1. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005;6:95-108
2. Wang WY, Barratt BJ, Clayton DG, et al. Genome-wide association studies: Theoretical and practical concerns. Nat Rev Genet 2005;6:109-118
3. Spencer CC, Su Z, Donnelly P, et al. Designing genome-wide association studies: Sample size, power, imputation, and the choice of genotyping chip. PLoS Genet 2009;5(5):e1000477
4. Mufano MR, Flint J. Meta-analysis of genetic association studies. Trends Genet 2005;21(5):268-269
5. Clark AG, Boerwinkle E, Hixson J, et al. Determinants of the success of whole-genome association testing. Genome Res 2005;15:1463-1467
6. Thornton-Wells TA, Moore JH, Haines JL. Genetics, statistics and human disease: Analytical retooling for complexity. Trends Genet 2004;20:640-647
7. Levy PA. Inborn errors of metabolism: Part 2: Specific disorders. Pediatr Rev 2009;4:e22-8
8. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: Principles of pathogenesis and therapy. Lancet 2005;365(9467):1333-1346
9. Mahler RJ, Adler ML. Type II diabetes mellitus: Update on diagnosis, pathophysiology, and treatment. J Clin Endocrinol Metab 1999;84(4):1165-1171
10. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type II diabetes. Diabetologia 2003;46:3-19
11. Inzucchi SE, Sherwin RS. The prevention of type 2 diabetes mellitus. Endocrinol Metab Clin N Am 2007;34:199-219
12. Bolen S, Feldman L, Vassy J, et al. Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 2007;147(6):386-399
13. Eberhart MS, Ogden C, EngelgauM, et al. Prevalence of Overweight and Obesity Among Adults with Diagnosed Diabetes -United States, 1988-1994 and 1999-2002. Morbidity and mortality weekly report. Centers Disease Control Prevention 2004;53(45):1066-1068
14. Ridderstråle M, Groop L. Genetic dissection of type 2 diabetes. Mol Cell Endocrinol 2009;297(1-2):10-17
15. Newman B, Selby JV, King MC, et al. Concordance for type 2 diabetes in male twins. Diabetologia 1987;30:763-768
16. Groop L, Forsblom C, Lehtovirta M, et al. Metabolic consequences of a family history of NIDDM (the Botnia study): Evidence for sex-specific parental effects. Diabetes 1996;45(11):1585-1593
17. Horikawa Y, Oda N, Cox NJ, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000;26:163-175
18. Parikh H, Groop L. Candidate genes for type 2 diabetes. Rev Endocr Metab Disord 2004;5:151-176
19. Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006;38:320-323
20. Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000;26:76-80
21. Gloyn AL, Weedon MN, Owen KR, et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunit Kir 6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCJN11W23K variant is associated with type 2 diabetes. Diabetes 2003:52:568-572
22. Florez JC, Burtt N, de Bakker PIW, et al. Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor (SUR1) and the islet ATP- sensitive potassium channel (kir 6.2) gene region. Diabetes 2004;3:1360-1368
23. Gudmundsson J, Sulem P, Steinthorsdottir V, et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 2007;39:977-983
24. Zeggini E, Scott LJ, Saxena R, et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008;40(5):638-645
25. Sandhu MS, Weedon MN, Fawcett KA, et al. Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet 2007;39:951-953
26. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003;34(3):267-273
27. Sookoian S, Garcia SI, Porto PI, et al. Peroxisome proliferator-activated receptor gamma and its coactivator-1 alpha may be associated with features of the metabolic syndrome in adolescents. J Mol Endocrinol 2005;35(2):373-380
28. Grarup N, Rose CS, Andersson EA, et al. Studies of association of variants near the HHEX, CDKN2A/2B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10 705 Danish subjects: validation and extension of genome-wide association studies. Diabetes 2007;56:3105-3111
29. Pascoe L, Tura A, Patel SK, et al. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes 2007;56:3101-3104
30. Staiger H, Stancakova A, Zilinskaite J, et al. A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: Results from the EUGENE2 study. Diabetes 2008;57:514-517
31. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007;39:770-775
32. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007;445(7130):881-885
33. Yasuda K, Miyake K, Horikawa Y, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008;40(9):1092-1097
34. Unoki H, Takahashi A, Kawaguchi T, et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations Nat Genet 2008;40(9):1098-1102
35. Popkin BM, Gordon-Larsen P. The nutrition transition: Worldwide obesity dynamics and their determinants. Int J Obesity 2004;28:S2-9
36. Mendez M, Popkin BM. Globalization, urbanization and nutritional change in the developing world. J Agr Dev Econ 2004;1(2):220-241
37. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295(13):1549-1555
38. Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet 2005;6:221-234
39. Samaras K, Spector TD, Nguyen TV, et al. Independent genetic factors determine the amount and distribution of fat in women after the menopause. J Clin Endocrinol Metab 1997;82(3):781-785
40. Rankinen T, Zuberi A, Chagnon YC, et al. The human obesity map: 2005 update. Obesity 2006;14(4):530-644
41. Suviolahti E, Oksanen LJ, Ohman M, et al. The SLC6A14 gene shows evidence of association with obesity. J Clin Invest 2003;112(11):1762-1772
42. Durand E, Boutin P, Meyre D, et al. Polymorphisms in the amino acid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians. Diabetes 2004;53(9):2483-2486
43. Sookoian S, Gemma C, Garcia SI, et al. Short allele of serotonin transporter gene promoter is a risk factor for obesity in adolescents. Obesity (Silver Spring) 2007;15(2):271-276
44. Sookoian S, Gianotti TF, Gemma C, et al. Contribution of the functional 5-HTTLPR variant of the SLC6A4 gene to obesity risk in male adults. Obesity (Silver Spring) 2008;16(2):488-491
45. Nilsson BM. 5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents. J Med Chem 2006;49:4023-4034
46. Rosmond R, Bouchard C, Bjorntorp P. 5-HT2A receptor gene promoter polymorphism in relation to abdominal obesity and cortisol. Obes Res 2002;10(7):585-589 (Pubitemid 135688255)
47. Zhou L, Sutton GM, Rochford JJ, et al. Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metabolism 2007;6(5):398-405
48. Sookoian S, Gemma C, Gianotti TF, et al. Genetic variants of clock transcription factor are associated with individual susceptibility to obesity. Am J Clin Nutr 2008 J;87(6):1606-1615
49. Sookoian SC, Gonzalez C, Pirola CJ. Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome. Obes Res 2005;13(12):2122-2131
50. Liu Y, Lui X, Wang L, et al. Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. Hum Mol Genet 2008;17(12):1803-1813
51. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007;316(5826):889-894
52. Saunders CL, Chiodini BD, Sham P, et al. Meta-analysis of genome-wide linkage studies in BMI and obesity. Obesity 2007;15(9):2263-2275
53. Chung WK, Leibel RL. Considerations regarding the genetics of obesity. Obesity 2008;16(Suppl 3):S33-9
54. Peters T, Ausmeier K, Rüther U. Cloning of Fatso (Fto), a novel gene deleted by the Fused toes (Ft) mouse mutation. Mamm Genome 1999;10(10):983-986
55. Sanchez-Pulido L, Andrade-Navarro MA. The FTO (fat mass and obesity associated) gene codes for a novel member of the non-heme dioxygenase superfamily. BMC Biochem 2007;8:23
56. Fischer J, Koch L, Emmerling C, et al. Inactivation of the Fto gene protects from obesity. Nature 2009;458(7240):894-898
57. Viasse C, Clement K, Guy-Grand B, et al. A frameshift mutation in human MCR4 is associated with a dominant form of obesity. Nat Genet 2000;20:113-114
58. Branson R, Potoczna N, Kral JG, et al. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003;348(12):1096-1103
59. Farooqi IS, Keogh JM, Yeo GS, et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003;348(12):1085- 1095
60. Chambers JC, Elliot P, Zebaneh D, et al. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet 2008;40(6):716-718
61. Loos RJ, Lindgren CM, Li S, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008;40(6):768-775
62. Herbert A, Gerry NP, MacQueen MB, et al. A common genetic variant associated with adult and childhood obesity. Science 2006;312:279
63. Lyon HN, Emilsson V, Hinney A, et al. The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. PLoS Genet 2007;3(4):e61
64. Deng HW, Deng H, Liu YJ, et al. A genome-wide linkage scan for quantitative-trait loci for obesity phenotypes. Am J Hum Genet 2002;70:1138-1151
65. Takaishi K, Duplomb L, Wang MY, et al. Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats. Proc Natl Acad Sci USA 2004;101(18):7106-7111
66. Renström F, Payne F, Nordström A, et al. Replication and extension of genome-wide association study results for obesity in 4923 adults from northern Sweden. Hum Mol Genet 2009;18(8):1489-1496
67. Scuteri A, Sanna S, Chen WM, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 2007;3(7):e115
68. Thorleifsson G, Walters GB, Gudbjartsson DF, et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 2009;41(1):18-24
69. Meyre D, Delplanque J, Chèvre JC, et al. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet 2009;41(2):157-159
70. Lindgren CL, Heid IM, Randall JC, et al. Genome-wide association scan meta-analysis identifies three loci influencing adiposity and fat distribution. PLoS Genet 2009;5(6):e1000508
71. Heard-Costa NL, Zillikens MC, Monda KL, et al. NRXN4 is a novel locus for waist circumference: A genome-wide association study from the CHARGE consortium. PLoS Genet 2009;5(6);e1000539
72. Cheng CY, Kao WHL, Patterson N, et al. Admixture mapping of 15,280 African Americans identifies obesity susceptibility loci on chromosomes 5 and X. PLoS Genet 2009;5(5):e1000490
73. Pearson TA, Manolio TA. How to interpret a genome-wide association study. JAMA 2008;299(11):1335-1344
74. Chanock SJ, Manolio T, Boehnke M, et al. Replicating genotype-phenotype associations. Nature 2007;447:655-660
75. Hunter DJ, Kraft P. Drinking from the fire hose-statistical issues in genome-wide association studies. N Engl J Med 2007;357(5):436-439
76. Greene CS, Moore JH. Solving complex problems in human genetics using nature-inspired algorithms requires strategies which exploit domain-specific knowledge. Nature Inspired Informatics, IGI Global; 2009;7:166-180
77. Greene CS, Penrod NM, Williams SM, et al. Failure to replicate a genetic association may provide important clues about genetic architecture. PLoS ONE 2009;4:e5639
78. Bush WS, Dudek SM, Ritchie MD. Biofilter: A knowledge-integration system for the multi-locus analysis of genome-wide association studies. Pac Symp Biocomput 2009;368-379
79. Saccone SF, Saccone NL, Swan GE, et al. Systematic biological prioritization after a genome-wide association study: An application to nicotine dependence. Bioinformatics 2008;24:1805-1811
80. Yu K, Li Q, Bergen AW, et al. Pathway analysis by adaptive combination of P-values. Genet Epidemiol 2009; [Epub ahead of print]
81. Askland K, Read C, Moore J. Pathways-based analyses of whole-genome association study data in bipolar disorder reveal genes mediating ion channel activity and synaptic neurotransmission. Hum Genet 2009;125:63-79
82. Wilke RA, Mareedu RK, Moore JH. The pathway less traveled: Moving from candidate genes to candidate pathways in the analysis of genome-wide data from large scale pharmacogenetic association studies. Curr Pharmacogenomics Personalized Med 2008;6:150-159
83. Moore JH. From genotype to genometype: Putting the genome back in genome-wide association studies. Eur J Hum Genet 2009;17(10):1231-1240
84. Moore JH , Ritchie MD. The challenges of whole-genome approaches to common diseases. JAMA 2004;291:1642-1643
85. Lewontin RC. The analysis of variance and the analysis of causes. Am J Hum Genet 1974;26:400-411
86. Lewontin RC. Commentary: Statistical analysis or biological analysis as tools for understanding biological causes. Int J Epidemiol 2006;35:536-537
87. Wahlsten D. Insensitivity of the analysis of variance to heredity-environment interactions. Behav Brain Sci 1990;13:109-161
88. Mitchell T. Machine learning. McGraw-Hill, New York; 2009.
89. Hastie T, Tibshirani R, Friedman J. The of statistical learning: Data mining, inference, and prediction. Springer-Verlag, New York; 2009.
90. McKinney BA, Reif DM, White BC, et al. Evaporative cooling feature selection for genotypic data involving interactions. Bioinformatics 2007;23:2113-2120
91. Motsinger AA, Ritchie MD, Dobrin SE. Clinical applications of whole-genome association studies: Future applications at the bedside. Expert Rev Mol Diagn 2006;6(4):551-565
92. Cordell HJ. Genome-wide association studies: Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet 2009. [Epub ahead of print]
93. Tiffin N, Adie E, Turner F, et al. Computational disease gene identification: A concert of methods prioritizes type 2 diabetes and obesity candidate genes. Nucleic Acids Res 2009;34(10):3067-3081
94. Chen J, Aronow B, Jegga A. Disease candidate gene identification and prioritization using protein interaction networks. BMC Bioinformatics 2009;10(1):73
95. Aerts S, Lambrechts D, Maity S, et al. Gene prioritization through genomic data fusion. Nat Biotechnol 2006;24(5):537-544
96. Medina I, Montaner D, Bonifaci N, et al. Gene set-based analysis of polymorphisms: Finding pathways or biological processes associated to traits in genome-wide association studies. Nucleic Acids Res 2009;37(Suppl 2):W340-4
97. Perez-Iratxeta C, Wjst M, Bork P, Andrade MA. G2D: A tool for mining genes associated with disease. BMC Genet 2005;6:45
98. Moore JH, Williams SW. Traversing the conceptual divide between biological and statistical epistasis: Systems biology and a more modern synthesis. BioEssays 2005;27:637-646
99. Amos CI. Successful design and conduct of genome-wide association studies. Hum Mol Genet 2007;16(2):R220-5
100. Price AL, Patterson N, Yu F, et al. A genome-wide admixture map for Latino populations. Am J Hum Genet 2007;80:1024-1036
101. Tian C, Hind DA, Shigeta R, et al. A genome-wide single nucleotide polymorphism panel with high ancestry information for African American admixture mapping. Am J Hum Genet 2006;79:640-649
102. Smith MW, Patterson N, Lautenberger JA, et al. A high density admixture map for disease gene discovery in African-Americans. Am J Hum Genet 2004;74:1001-1013
103. Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 1999;65:220-228
104. Price AL, Patterson NJ, Plenge RM, et al. Principle components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909
105. Epstein MP, Allen AS, Satten GA. A simple and improved correction for population stratification in case-control studies. Am J Hum Genet 2007;80:921-930
106. Emily M, Mailund T, Hein J, et al. Using biological networks to search for interacting loci in genome-wide association studies. Eur J Hum Genet 2009. [Epub ahead of print 11 March]
107. Pattin KA, Moore JH. Exploiting the proteome to improve the genome-wide genetic analysis of epistasis in common human diseases. Hum Genet 2008;124:19-29
108. Franke L, van Bakel H, Fokkens L, et al. Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes. Am J Hum Genet 2006;78:1011-1025
109. Green CS, Moore JH. Ant colony optimization for genome-wide genetic analysis. Lect Notes. Comput Sci 2008;5217:37-47
110. Moore JH, White BC. Tuning ReliefF for genome-wide genetic analysis. Lect Notes Comput Sci 2007;166-177